James W McCollum insider trades
Open-market stock purchases and sales by James W McCollum, Director at LENZ Therapeutics, Inc, from SEC Form 4 filings since Mar 21, 2024.
Track record: 0% of 2 scored buys are up 5% or more since purchase, averaging -66%.
Companies traded
- LENZ LENZ Therapeutics, Inc: 2 buys, last Jun 15, 2026